Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at SAR 34.2B, ahead of BioNTech (SAR 31.9B) and Gilead Sciences (SAR 28.4B). Figures as of 18 Nov 2026, 21:28 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenSAR 34.2B
Median
SAR 1.6B
Combined market value
SAR 3.14T
Countries
5

Market values as of .

All countries
All sectors
Biotech
SAR
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareSAR 34.2BSAR 900.6BSAR 1,665.03 3.07% down 34% up United States
2BioNTechBNTX · Health CareSAR 31.9BSAR 77.4BSAR 312.31 1.89% down 16% down Germany
3Gilead SciencesGILD · Health CareSAR 28.4BSAR 786.2BSAR 633.84 0.75% down 33% up United States
4argenxARGX · Health CareSAR 13.1BSAR 222BSAR 3,530.63 0.66% down 4% up Belgium
5BiogenBIIB · Health CareSAR 11.3BSAR 139.4BSAR 943.04 0.25% up 49% up United States
6ModernaMRNA · Health CareSAR 9.7BSAR 298.7BSAR 738.16 4.84% down 755% up United States
7ImmunovantIMVT · Health CareSAR 3.4BSAR 25.7BSAR 124.42 0.12% down 43% up United States
8QiagenQGEN · Health CareSAR 3.1BSAR 38.4BSAR 185.90 0.38% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareSAR 2.7BSAR 61.8BSAR 610.89 1.84% down 20% up United States
10RepligenRGEN · Health CareSAR 2.1BSAR 41.4BSAR 647.69 6.47% up 5% up United States
11Krystal BiotechKRYS · Health CareSAR 1.9BSAR 35.1BSAR 1,182.84 5.62% up 46% up United States
12ExelixisEXEL · Health CareSAR 1.8BSAR 62.5BSAR 256.16 0.31% down 63% up United States
13Revolution MedicinesRVMD · Health CareSAR 1.4BSAR 129.7BSAR 599.48 1.76% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareSAR 1.3BSAR 38.8BSAR 454.36 0.32% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareSAR 1.3BSAR 14.6BSAR 150.75 0.10% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareSAR 1.2BSAR 22BSAR 180.05 6.48% up 14% up United States
17Bio-TechneTECH · Health CareSAR 992.9MSAR 42.9BSAR 272.89 0.17% up 26% up United States
18Kodiak SciencesKOD · Health CareSAR 787.2MSAR 24BSAR 366.89 1.04% up 396% up United States
19Twist BioscienceTWST · Health CareSAR 686.6MSAR 29.8BSAR 436.43 3.88% up 340% up United States
20VaxcytePCVX · Health CareSAR 652.5MSAR 34.7BSAR 219.51 1.48% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareSAR 502MSAR 41BSAR 359.35 0.18% down 37% up United States
22ImmunityBioIBRX · Health CareSAR 331.3MSAR 26.7BSAR 25.13 7.03% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareSAR 264.4MSAR 17.3BSAR 106.75 0.11% down 88% up United States
24CG OncologyCGON · Health CareSAR 121.9MSAR 26.8BSAR 300.08 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (SAR 34.2B), BioNTech (SAR 31.9B) and Gilead Sciences (SAR 28.4B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 21:28 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of SAR 3.14T as of 18 Nov 2026, 21:28 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.